Reviews
Drug-induced Fanconi's syndrome

https://doi.org/10.1053/ajkd.2003.50037Get rights and content

Abstract

Fanconi's syndrome (FS) was first described by Lignac in 1924. Associated with numerous varieties of inherited and acquired conditions, FS is characterized by a generalized transport defect in the proximal tubules, leading to renal losses of glucose, phosphate, calcium, uric acid, amino acids, bicarbonates, and other organic compounds. Cardinal symptoms of the syndrome are hyperaminoaciduria, glucosuria in the face of a normal serum glucose level, and phosphate wasting. Other symptoms may be associated, such as defects in bicarbonate reabsorption; renal acidification; urate reabsorption; urinary concentration; potassium conservation; reabsorption of sodium, calcium, and low-molecular-weight proteins; and secretion of p-aminohippuric acid. Acquired renal tubular defects resulting in FS also have been described in association with many exogenous agents, whether administered or accidentally ingested. This review concentrates on drug-induced FS. Am J Kidney Dis 41:292-309.

References (0)

Cited by (204)

  • Acquired disorders of phosphaturia: Beyond tumor-induced osteomalacia

    2024, Best Practice and Research: Clinical Endocrinology and Metabolism
  • Overview of Antibiotic-Induced Nephrotoxicity

    2023, Kidney International Reports
  • Lack of xanthine dehydrogenase leads to a remarkable renal decline in a novel hypouricemic rat model

    2022, iScience
    Citation Excerpt :

    Clinical conditions presenting with hypouricemia can be classified as disorders of decreased UA production or increased UA urinary excretion (hyperuricosuria) (Pineda et al., 2019). In both categories, there are inherited conditions (hereditary xanthinuria, purine nucleoside phosphorylase deficiency, hereditary renal hypouricemia types 1 & 2 (RHUC1 & 2)) as well as acquired disorders (overcorrection by UA-lowering therapy, liver disease (Michelis et al., 1974), malnutrition, Fanconi syndrome (Izzedine et al., 2003), diabetes mellitus, and so forth) resulting in hypouricemia. Although most clinical cases of hypouricemia present asymptomatically, some complications such as acute kidney injury (AKI) (Ichida et al., 2004; Ishikawa et al., 1990; Ohta et al., 2004), nephrolithiasis, and posterior reversible encephalopathy syndrome have been reported (Fujinaga et al., 2013).

  • Fanconi syndrome and euglycemic diabetic ketoacidosis secondary to canagliflozin use in a type 2 diabetic

    2022, Journal of Clinical and Translational Endocrinology: Case Reports
  • Renal toxicity of anticancer drugs

    2021, Nephrologie et Therapeutique
View all citing articles on Scopus
View full text